Fueyo J - Search Results

1

Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.

Lamfers ML, Grill J, Dirven CM, Van Beusechem VW, Geoerger B, Van Den Berg J, Alemany R, Fueyo J, Curiel DT, Vassal G, Pinedo HM, Vandertop WP, Gerritsen WR. Lamfers ML, et al. Among authors: fueyo j. Cancer Res. 2002 Oct 15;62(20):5736-42. Cancer Res. 2002. PMID: 12384532

2

Suppression of human glioma growth by adenovirus-mediated Rb gene transfer.

Fueyo J, Gomez-Manzano C, Yung WK, Liu TJ, Alemany R, Bruner JM, Chintala SK, Rao JS, Levin VA, Kyritsis AP. Fueyo J, et al. Neurology. 1998 May;50(5):1307-15. doi: 10.1212/wnl.50.5.1307. Neurology. 1998. PMID: 9595979

3

Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses.

Alemany R, Gomez-Manzano C, Balagué C, Yung WK, Curiel DT, Kyritsis AP, Fueyo J. Alemany R, et al. Among authors: fueyo j. Exp Cell Res. 1999 Oct 10;252(1):1-12. doi: 10.1006/excr.1999.4623. Exp Cell Res. 1999. PMID: 10502394 Review.

4

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

Fueyo J, Gomez-Manzano C, Alemany R, Lee PS, McDonnell TJ, Mitlianga P, Shi YX, Levin VA, Yung WK, Kyritsis AP. Fueyo J, et al. Oncogene. 2000 Jan 6;19(1):2-12. doi: 10.1038/sj.onc.1203251. Oncogene. 2000. PMID: 10644974

5

A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency.

Suzuki K, Fueyo J, Krasnykh V, Reynolds PN, Curiel DT, Alemany R. Suzuki K, et al. Among authors: fueyo j. Clin Cancer Res. 2001 Jan;7(1):120-6. Clin Cancer Res. 2001. PMID: 11205899

6

[Oncolytic adenovirus for the treatment of cerebral tumors: past, present and future].

Alemany R, Gómez-Manzano C, Fueyo J. Alemany R, et al. Among authors: fueyo j. Neurologia. 2001 Mar;16(3):122-7. Neurologia. 2001. PMID: 11333782 Review. Spanish.

7

Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.

Fueyo J, Alemany R, Gomez-Manzano C, Fuller GN, Khan A, Conrad CA, Liu TJ, Jiang H, Lemoine MG, Suzuki K, Sawaya R, Curiel DT, Yung WK, Lang FF. Fueyo J, et al. J Natl Cancer Inst. 2003 May 7;95(9):652-60. doi: 10.1093/jnci/95.9.652. J Natl Cancer Inst. 2003. PMID: 12734316

8

A novel E1A-E1B mutant adenovirus induces glioma regression in vivo.

Gomez-Manzano C, Balague C, Alemany R, Lemoine MG, Mitlianga P, Jiang H, Khan A, Alonso M, Lang FF, Conrad CA, Liu TJ, Bekele BN, Yung WK, Fueyo J. Gomez-Manzano C, et al. Among authors: fueyo j. Oncogene. 2004 Mar 11;23(10):1821-8. doi: 10.1038/sj.onc.1207321. Oncogene. 2004. PMID: 15014451

9

Genetically modified adenoviruses against gliomas: from bench to bedside.

Gomez-Manzano C, Yung WK, Alemany R, Fueyo J. Gomez-Manzano C, et al. Among authors: fueyo j. Neurology. 2004 Aug 10;63(3):418-26. doi: 10.1212/01.wnl.0000133302.15022.7f. Neurology. 2004. PMID: 15304571 Review.

10

Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas.

Jiang H, Gomez-Manzano C, Alemany R, Medrano D, Alonso M, Bekele BN, Lin E, Conrad CC, Yung WK, Fueyo J. Jiang H, et al. Among authors: fueyo j. Neoplasia. 2005 Jan;7(1):48-56. doi: 10.1593/neo.04391. Neoplasia. 2005. PMID: 15720816 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters